Human CellExp FABP-3, human recombinant protein
FABP3, H-FABP, FABP11, MDGI, M-FABP, hFABP, O-FABP
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P05413 |
---|---|
Calculated MW | The protein is fused with 6×His tag at the C-terminus, has a calculated MW of 15.7 kDa. The predicted N-terminus is Met 1. DTT-reduced Protein migrates as 16 kDa. |
Gene ID | 2170 |
---|---|
Gene Symbol | FABP3 |
Other Names | FABP3, H-FABP, FABP11, MDGI, M-FABP, hFABP, O-FABP |
Gene Source | Human |
Source | HEK 293 cells |
Assay&Purity | SDS-PAGE; ≥92% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Target/Specificity | FABP3 |
Application Notes | Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C. |
Format | Lyophilized powder |
Storage | -20°C; Lyophilized from 0.22 µm filtered solution in PBS. Generally 5-8% Mannitol or trehalose is added as a protectant before lyophilization. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Fatty acid-binding protein 3 (FABP3) also known as Heart-type fatty acid binding protein (H-FABP), Mammary-derived growth inhibitor (MDGI), Muscle fatty acid-binding protein (M-FABP), FABP11, which belongs to the calycin superfamily and fatty-acid binding protein (FABP) family. FABP are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. H-FABP / FABP3 is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for oxidation. FABP3 may also contribute to AS160 phosphorylation by maintaining insulin-dependent Akt activation in the cells under a lipotoxic condition.
References
Peeter R.A.,et al.Biochem. J. 276:203-207(1991).
Hu Y.F.,et al.Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
Wu X.,et al.Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
Kalnine N.,et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.